About NewsLine Media
| NewsLine Media is a Digital Communications Company providing all aspects of Internet commerce and marketing. The Internet is still the digital frontier and technology is changing daily. NewsLine Media was created to meet the challenge by keeping our clients ahead of the curve. With the promise of "Open Source" providing new design tools such as Joomla and Drupal, come new problems that threaten the securinty and integrity of sites using this technology. NewsLine Media provides daily oversight with secure hosting and 24/7 oversight of all the sites we build. We have over 100 years of combined experience in this field and are dedicated to constantly improving. Meet our management team: | |
 |
Peter Vaka is the President and head design architect. For more than 20 years he has helped companies in the private sector and the U.S. Government improve their online presence. NewsLine Media was established in 2000 at the turn of the century. Since that time we have successfully helped launch dozens of new companies, products, and programs. Peter came into the electronic age as a newspaper publisher in need of a better way to provide the news when the price of ink and paper threatened to put his company out of business. He now helps others to tell their story. |
| Peter Vaka | |
 |
Mr. Gambacorta is VP of Marketing and is a professional marketing consultant with many years of experience in digital marketing for numerous companies. Mr. Gambacorta has been published in several national healthcare and Military Training marketing publications and he has been a frequent featured speaker at national conventions and seminars. Peter Gambacorta has been associated with marketing most of his career. For the majority of his career Mr. Gambacorta was involved in the biotechnology and pharmaceutical industry where he held various positions to include Senior Vice President, National Sales Director and conducted marketing on a national and regional level. He also designed and implemented national marketing campaigns for the pharmaceutical and biotechnology industries. |
| Peter Gambacorta | |